Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Prognostic and Predictive Value of PETSCAn in ColoRectal Cancer (CRC)

NCT00741481 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT00741481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00741481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Prognostic and Predictive Value of PETSCAn in ColoRectal Cancer (CRC)
Lead sponsor
Jules Bordet Institute
Phase
Observational
Overall status
Completed
Start date
June 30, 2006
Completion date
July 31, 2010
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic, early response evaluation, fdg-pet